Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The capsular polysaccharide–carrier protein conjugate linkage is the covalent bond that joins a bacterial capsular polysaccharide to a carrier protein, a fundamental architecture in conjugate vaccines (Pace, D., 2013, Expert Opinion on Biological Therapy). Bacterial polysaccharides are typically T-cell independent antigens that do not elicit long-term memory or effective responses in infants (Pollard, A. J., et al., 2009, WHO). By chemically linking these sugars to a protein carrier, such as CRM197 or tetanus toxoid, the vaccine recruits T-helper cells, transforming the immune response into a T-cell dependent one (Rappuoli, R., 2018, Science Translational Medicine). This process enables the production of high-affinity IgG antibodies and the establishment of immunological memory. This linkage is crucial for the efficacy of vaccines against pathogens like Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b (CDC, 2022). The specific chemistry of the linkage, whether through reductive amination or spacer molecules, significantly influences the stability and immunogenicity of the resulting vaccine (Frasch, C. E., 2009, Methods in Molecular Biology). It represents a critical design element in vaccinology rather than a traditional biological receptor or enzyme target. Optimization of this linkage is a key focus in developing next-generation multivalent vaccines to prevent interference and maximize protective titers.
The linkage facilitates the conversion of T-independent polysaccharide antigens into T-dependent antigens by providing a protein scaffold that can be processed and presented by B cells to T-helper cells via MHC class II molecules, leading to B-cell maturation, isotype switching to IgG, and memory B-cell formation (Avci, F. Y., et al., 2011, Nature Medicine; Rappuoli, R., 2018, Science Translational Medicine).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capsular polysaccharide–carrier protein conjugate linkage.